These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 19276987

  • 1. Effects of levosimendan on the energy balance: preclinical and clinical evidence.
    Nieminen MS, Pollesello P, Vajda G, Papp Z.
    J Cardiovasc Pharmacol; 2009 Apr; 53(4):302-10. PubMed ID: 19276987
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C, Tousoulis D, Koumallos N, Marinou K, Stefanadis C.
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Levosimendan: dual mechanisms for acute heart failure...and beyond?
    Ng TM, Akhter MW.
    Minerva Cardioangiol; 2005 Dec; 53(6):565-84. PubMed ID: 16333239
    [Abstract] [Full Text] [Related]

  • 7. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
    Meyer K, Klocke RC, Schipke JD, Gams E, Korbmacher B.
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):326-31. PubMed ID: 18539040
    [Abstract] [Full Text] [Related]

  • 8. Levosimendan: current status and future prospects.
    Archan S, Toller W.
    Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The utility of levosimendan in the treatment of heart failure.
    Lehtonen L, Põder P.
    Ann Med; 2007 Feb; 39(1):2-17. PubMed ID: 17364447
    [Abstract] [Full Text] [Related]

  • 12. The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
    Cavana M, Pignataro C, Fraticelli A, Mebazaa A.
    Ital Heart J; 2003 May; 4 Suppl 2():61S-64S. PubMed ID: 14635372
    [Abstract] [Full Text] [Related]

  • 13. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT, Paraskevaidis I, Bistola V, Farmakis D, Panou F, Kourea K, Nikolaou M, Filippatos G, Kremastinos D.
    Am J Cardiol; 2006 Dec 01; 98(11):1489-92. PubMed ID: 17126656
    [Abstract] [Full Text] [Related]

  • 14. Cardioprotection: a new paradigm in the management of acute heart failure syndromes.
    Maytin M, Colucci WS.
    Am J Cardiol; 2005 Sep 19; 96(6A):26G-31G. PubMed ID: 16181820
    [Abstract] [Full Text] [Related]

  • 15. Levosimendan: from basic science to clinical trials.
    Rognoni A, Lupi A, Lazzero M, Bongo AS, Rognoni G.
    Recent Pat Cardiovasc Drug Discov; 2011 Jan 19; 6(1):9-15. PubMed ID: 21208157
    [Abstract] [Full Text] [Related]

  • 16. Levosimendan in the treatment of cardiogenic shock.
    Buerkem B, Lemm H, Krohe K, Dietz S, Raaz U, Buerke U, Russ M, Schlitt A, Werdan K.
    Minerva Cardioangiol; 2010 Aug 19; 58(4):519-30. PubMed ID: 20938415
    [Abstract] [Full Text] [Related]

  • 17. Levosimendan increases portal blood flow and attenuates intestinal intramucosal acidosis in experimental septic shock.
    García-Septien J, Lorente JA, Delgado MA, de Paula M, Nin N, Moscoso A, Sánchez-Ferrer A, Perez-Vizcaino F, Esteban A.
    Shock; 2010 Sep 19; 34(3):275-80. PubMed ID: 19997054
    [Abstract] [Full Text] [Related]

  • 18. Is calcium sensitization the best strategy to improve myocardial contractility in acute heart failure?
    Erhardt LR.
    Ital Heart J; 2003 May 19; 4 Suppl 2():27S-33S. PubMed ID: 14635367
    [Abstract] [Full Text] [Related]

  • 19. Milrinone and levosimendan during porcine myocardial ischemia -- no effects on calcium overload and metabolism.
    Axelsson B, Johansson G, Abrahamsson P, Gupta A, Tydén H, Wouters P, Haney M.
    Acta Anaesthesiol Scand; 2013 Jul 19; 57(6):719-28. PubMed ID: 23517167
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF, Shekerdemian LS, Nørgaard MA, Brizard CP, Mynard JP, Horton SB, Penny DJ.
    Crit Care Med; 2007 Jan 19; 35(1):252-9. PubMed ID: 17133188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.